GP Clinical Template Letter – Includes Treatment
... The treatment they have had, any ongoing treatment, and possible side effects Signs and symptoms to report Where to find further help and support – including how to contact the dedicated helpline if they have any concerns Please find enclosed a copy of their treatment summary which outlines wh ...
... The treatment they have had, any ongoing treatment, and possible side effects Signs and symptoms to report Where to find further help and support – including how to contact the dedicated helpline if they have any concerns Please find enclosed a copy of their treatment summary which outlines wh ...
prostate ca - Chesterfield Urology
... size of a walnut, and it helps produce seminal fluid-the fluid in which sperm are carried out of the body as part of semen. The prostate gland encircles the urethra-the tube that carries urine away from the bladder. What is prostate cancer: As men age, they are at greater risk for developing prostat ...
... size of a walnut, and it helps produce seminal fluid-the fluid in which sperm are carried out of the body as part of semen. The prostate gland encircles the urethra-the tube that carries urine away from the bladder. What is prostate cancer: As men age, they are at greater risk for developing prostat ...
How to reduce suffering and death from Prostate cancer…. Lessons
... Patient with Low GC: No difference in met free survival Decipher low-‐risk (GC < 0.4) ...
... Patient with Low GC: No difference in met free survival Decipher low-‐risk (GC < 0.4) ...
Localized Prostate Cancer - Penn State College of Medicine
... years; this is the highest age-specific incidence of any cancer. As compared with white men, black men have a 40% higher risk of the disease and twice the rate of death. The mortality due to prostate cancer has steadily declined for a decade, and it decreased by 4% per year between 1999 and 2003. Th ...
... years; this is the highest age-specific incidence of any cancer. As compared with white men, black men have a 40% higher risk of the disease and twice the rate of death. The mortality due to prostate cancer has steadily declined for a decade, and it decreased by 4% per year between 1999 and 2003. Th ...
CEA - yeditepetip4
... • Level should change in response to tumor size • An abnormal level should be obtained in the presence of micrometastases • The level should not have large fluctuations that are independent of changes in tumor size • Levels in healthy individuals are at much lower concentrations than those found in ...
... • Level should change in response to tumor size • An abnormal level should be obtained in the presence of micrometastases • The level should not have large fluctuations that are independent of changes in tumor size • Levels in healthy individuals are at much lower concentrations than those found in ...
PSA Screening Decision-Making Aid
... differences are much larger for cancers found in men who had already been screened with a negative test result. Thus, there is little to say against this correct statement, but it has to be brought into context. 2. If the results of my PSA test are good, I will not worry as much. This statement is ...
... differences are much larger for cancers found in men who had already been screened with a negative test result. Thus, there is little to say against this correct statement, but it has to be brought into context. 2. If the results of my PSA test are good, I will not worry as much. This statement is ...
Prostate Cancer Screening Guideline
... surgery, and radiation therapy. There is no consensus regarding optimal treatment strategies, but—given the potential harms of definitive treatment—Kaiser Foundation Health Plan of Washington recommends considering active surveillance by a urologist for patients at low to intermediate risk. Treatmen ...
... surgery, and radiation therapy. There is no consensus regarding optimal treatment strategies, but—given the potential harms of definitive treatment—Kaiser Foundation Health Plan of Washington recommends considering active surveillance by a urologist for patients at low to intermediate risk. Treatmen ...
February 2015 - the website of Nottingham Prostate Cancer Support
... To read the full article press Ctrl+Click on the following link:http://www.icr.ac.uk/our-research/researchers-and-teams/professor-johann-de-bono ...
... To read the full article press Ctrl+Click on the following link:http://www.icr.ac.uk/our-research/researchers-and-teams/professor-johann-de-bono ...
Choline PET/CT
... Higher diagnostic accuracy to assess soft tissue than CT or MRI - finding disease within normal sized structures Power of fusion to minimize false positives Sensitivity may be preserved for low PSA recurrences-PSA <1.0 Already in the NCCN guidelines for restaging ...
... Higher diagnostic accuracy to assess soft tissue than CT or MRI - finding disease within normal sized structures Power of fusion to minimize false positives Sensitivity may be preserved for low PSA recurrences-PSA <1.0 Already in the NCCN guidelines for restaging ...
Radium-223 (Xofigo) for Treatment of Castration
... and prior to every dose of radium-223. Prior to the initial dose, patients must have absolute neutrophil count (ANC) greater than or equal to 1.5 x 109/L, platelet count greater than or equal to 100 x 109/L, and hemoglobin greater than or equal to 10 g/dL. Before subsequent administrations of radium ...
... and prior to every dose of radium-223. Prior to the initial dose, patients must have absolute neutrophil count (ANC) greater than or equal to 1.5 x 109/L, platelet count greater than or equal to 100 x 109/L, and hemoglobin greater than or equal to 10 g/dL. Before subsequent administrations of radium ...
An Introduction to PROSTATE CANCER
... stage and grade of the cancer, the man’s general health, and the man’s evaluation of the risks and benefits of each therapy option. During active surveillance, the cancer is carefully monitored for signs of progression. A PSA blood test and DRE are usually administered every six months along with a ...
... stage and grade of the cancer, the man’s general health, and the man’s evaluation of the risks and benefits of each therapy option. During active surveillance, the cancer is carefully monitored for signs of progression. A PSA blood test and DRE are usually administered every six months along with a ...
Pathological findings and PSA outcomes after - HAL
... survival (RFS) after radical prostatectomy (RP) [3]. For patients with organ-confined ...
... survival (RFS) after radical prostatectomy (RP) [3]. For patients with organ-confined ...
“Living Your Best After Cancer: You and Your Primary Care Doctor
... ulcerative colitis, Crohn’s or polyp history • Less use of stool testing, barium enema, sigmoidoscopy ...
... ulcerative colitis, Crohn’s or polyp history • Less use of stool testing, barium enema, sigmoidoscopy ...
A double-blind, placebo-controlled randomised trial - Pomi-T
... effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the UK NCRN Pomi-T study R Thomas1,2,3, M Williams1, H Sharma1, A Chaudry2 and P Bellamy3 BACKGROUND: Polyphenol-rich foods such as pomegranate, green tea, broccoli and turmeric have demonstrated anti-ne ...
... effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the UK NCRN Pomi-T study R Thomas1,2,3, M Williams1, H Sharma1, A Chaudry2 and P Bellamy3 BACKGROUND: Polyphenol-rich foods such as pomegranate, green tea, broccoli and turmeric have demonstrated anti-ne ...
Press release Helsingborg, Sweden, July 7, 2015 Glactone Pharma
... unmet medical need and few treatment options. Prostate cancer Prostate cancer (PCa) is the most common form of cancer in men in the developed world, and it ranks second in cancer-related deaths, with the vast majority of these fatalities resulting from metastatic disease. The management of prostate ...
... unmet medical need and few treatment options. Prostate cancer Prostate cancer (PCa) is the most common form of cancer in men in the developed world, and it ranks second in cancer-related deaths, with the vast majority of these fatalities resulting from metastatic disease. The management of prostate ...
- Prostate Cancer Foundation of Australia
... the cells in the body grow and behave. Every person has a set of many thousands of genes inherited from both parents. Changes to genes can increase the risk of prostate cancer being passed from parent to child. Although prostate cancer can’t be inherited, a man can inherit genes that can increase th ...
... the cells in the body grow and behave. Every person has a set of many thousands of genes inherited from both parents. Changes to genes can increase the risk of prostate cancer being passed from parent to child. Although prostate cancer can’t be inherited, a man can inherit genes that can increase th ...